Soligenix, Inc. (NASDAQ:SNGX – Free Report) – Stock analysts at Zacks Small Cap reduced their FY2025 earnings per share (EPS) estimates for Soligenix in a report issued on Tuesday, May 13th. Zacks Small Cap analyst D. Bautz now expects that the biopharmaceuti…